Recruiting
Comparative Effects of Alternative Nostril Breathing Versus Buteyko Breathing on Control Pause, Dyspnea and Pulmonary Function in Patients With Bronchial Asthma
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
ClinicalTrials.gov IDNCT07529847
PhaseNA
Enrollment46
SponsorFoundation University Islamabad
Age18 Years
SexALL
Conditions studied
Asthma (Diagnosis)
About this study
Bronchial asthma is a chronic inflmmatory airway disease characterized by recurrent episodes of dyspnea, wheezing, and airflow limitation. Dysfunctional breathing pattern and chronic hyperventilation
Interventions
- Other: Alternative Nostril Breathing Technique along with standard pharmacological management — Patients in this group will receive alternative nostril breathing technique along with standard pharmacological management. A total 4 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist and 5 days at home. Alternative nostril breathing will be performed in sitting position. The patient will be asked to place their right thumb to gently close their right nostril. Inhale slowly for 4 sec deeply through left nostril and hold breath for 2-3 sec. Release right nostril and use your right ring finger to close your left nostril. Exhale slowly 6 sec and completely through right nostril.Inhale slowly 4 sec and deeply through right nostril.Then hold breath for 2-3 sec. Patients will be asked to release the left nostril and use their right thumb to close their right nostril. Exhale slowly and completely through left nostril over 6 sec.Repeat the cycle. Pharmacological management: Patient will receive medications as per prescribed by pulmonologist
- Other: Buteyko breathing along with pharmacological management — Patient in this group will receive Buteyko breathing along with pharmacological management. A total 4 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and 5 days will be done by patients at home. The patient will sit comfortably in upright position. The patients will be give following instructions. Breathe normally for 2-3 minutes (nasal inhalation and nasal exhalation). After relax exhale, hold your breath, use index finger and thumb to plug nose. Retain your breath until you feel the urge to breathe (first sign of air hunger) then inhale. Breath normally for 10 sec. Repeat several times. Pharmacological management: Patient will receive medications as prescribed by pulmonologist
Primary outcomes
- Control Pause (04 weeks)
- Dyspnea (04 weeks)
- Pulmonary Function Test (04 weeks)
- Asthma Control (04 weeks)
Eligibility information
Inclusion Criteria:
* Age between 18-45 years
* Both genders (male and female)
* Grade 1-3 on mMRC scale of dyspnea
* Asthma severity classes- intermediate,mild persistent and moderate persistent asthma (acc. to NAEPP National Asthma Education and Prevention Program guidlines 2020)
Exclusion Criteria:
* Patients having acute exerbation of COPD/status asthmaticus
* Patients diagnosed with acute infection
* Patients unable to follow command and instructions
* Asthma patients with \>40sec control pause duration
Study locations
- Foundation University Islamabad, Islamabad, Pakistan
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.